Literature DB >> 2820572

Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group Study.

D L Trump1, P Elson, H Brodovsky, S E Vogl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820572

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II trial of carboplatin in patients with advanced germ-cell testicular tumors and transitional cell carcinomas of the urinary tract.

Authors:  H Akaza; M Hagiwara; N Deguchi; T Kawai; Y Satomi; T Matsuda; T Miki; T Ueda; T Kotake; H Tazaki
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer.

Authors:  A J Wagstaff; A Ward; P Benfield; R C Heel
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.